| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 53.86× | 53.86× | 66.57× | 75.25× | 74.16× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.83× | 2.85× | 3.18× | 2.61× | 2.53× | ||
| 0.72× | 0.72× | 0.73× | 0.83× | 0.79× | ||
| 1.01× | 1.01× | 0.93× | 1.16× | 0.39× | ||
| 0.94× | 0.94× | 0.90× | 1.01× | 0.32× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 74.16 | 75.25 | 66.57 | 53.86 | 53.86 | |
| Working Capital Turnover | 2.53 | 2.61 | 3.18 | 2.85 | 2.83 | |
| Asset Turnover | 0.79 | 0.83 | 0.73 | 0.72 | 0.72 | |
| Cash Conversion (CFO/Net Income) | 0.39 | 1.16 | 0.93 | 1.01 | 1.01 | |
| CFO/EBITDA | 0.32 | 1.01 | 0.90 | 0.94 | 0.94 |